Dana Farber Cancer Institute (Data Collection Only) | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment	Disease Attributes, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Simpson-Golabi-Behmel syndrome, hepatoblastoma, mixed neoplasm, neoplasm	Recruiting	Phase 1	2026-09-01		NCT04928677
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer	Surgery	Recruiting	Not applicable	2026-06-24		NCT06312124
A Registry for People With T-cell Lymphoma	ALK-negative anaplastic large cell lymphoma, ALK-positive anaplastic large cell lymphoma, Hemic and Lymphatic Diseases, Leukemia, Large Granular Lymphocytic, Lymphadenopathy, Lymphoma, Extranodal NK-T-Cell, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Sezary syndrome, T-cell leukemia, T-cell non-Hodgkin lymphoma, T-cell prolymphocytic leukemia, adult T-cell leukemia/lymphoma, aggressive NK-cell leukemia, anaplastic large cell lymphoma, angioimmunoblastic T-cell lymphoma, breast implant-associated anaplastic large cell lymphoma, enteropathy-associated T-cell lymphoma, extranodal nasal NK/T cell lymphoma, hematologic disorder, hepatosplenic T-cell lymphoma, hydroa vacciniforme-like lymphoma, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, monomorphic epitheliotropic intestinal T-cell lymphoma, mycosis fungoides, neoplasm, peripheral T-cell lymphoma, not otherwise specified, primary cutaneous T-cell lymphoma, primary cutaneous T-cell non-Hodgkin lymphoma, primary cutaneous anaplastic large cell lymphoma, prolymphocytic leukemia, subcutaneous panniculitis-like T-cell lymphoma	Recruiting	Not stated	2026-05-20		NCT05978141
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes	BRCA1/2; Genetic Testing	Recruiting	Not stated	2026-05-19		NCT03396341
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Malignant Peripheral Nerve Sheath Tumors, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Nerve Tissue, Urogenital Diseases, Urogenital Neoplasms, Wilms tumor, benign urinary system neoplasm, connective tissue neoplasm, fibrosarcoma, hereditary disease, hereditary neoplastic syndrome, kidney cancer, kidney disorder, mixed neoplasm, neoplasm, nerve sheath neoplasm, nervous system disorder, neurofibroma, neurofibrosarcoma, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, rhabdoid tumor, sarcoma, urinary system disorder	Recruiting	Phase 2	2026-05-06		NCT05985161
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Phase 2	2026-02-25		NCT06099769